New York Gov. Andrew Cuomo describes his meeting with President Donald Trump as productive. The two met at the White House Tuesday afternoon to discuss New York’s COVID-19 testing.
“The meeting went well and I think it was productive,” Andrew Cuomo told MSNBC in a phone interview, according to CNN. “The big issue was testing as everybody knows that's going to be the next step as we go forward.”
Cuomo said that he and Donald Trump worked out how the state and federal governments could cooperate. “And how do we separate the responsibilities and the tasks on testing vis-a-vis a state and the federal government and the acknowledgment that we will need to work together on this,” the New York governor added.
“It has to be a real partnership,” Cuomo said. “And I think we had a very good conversation.”
Andrew Cuomo also revealed that Donald Trump committed at a meeting in Washington Tuesday to “work together” to double New York’s rate of testing for COVID-19, CNBC reported. “It’s a very aggressive goal and we said that we would work together to meet that goal, so it was a very good conversation,” the governor said.
New York is the epicenter of the coronavirus crisis in the country and the state is testing about 20,000 people daily. Doubling that number would mean that it will be doing 40,000 COVID-19 tests per day.
Cuomo said that Trump “seemed very open and understanding” of the states’ need for federal funding while the struggling reopening their respective economies. “The states are in desperate shape and everything’s being left to the states to do the reopening ... They don’t provide any funding to the state government,” he said, adding that Trump “said the next piece of legislation that passes, he’s going to be open to that.”
Cuomo acknowledged that it is the states’ responsibility to determine where tests are taken as well as to regulate laboratories under their jurisdiction. However, he also pointed out that it is also the federal government’s role to “make the supply chain work for manufacturers.”


OpenAI Agent Breaches Australia Medicare Data Portal
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Macron Challenges Trump’s Gaza Peace Claims at UN
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
US Officials Split Over Response to Israeli West Bank Settlements
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
U.S. Issues Cuba Health Alert as Illnesses Rise
Ghana Says Western Support Growing for Slave Trade Reparations
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Russian Strikes Kill Eight Across Ukraine as Energy Sites Hit
Kremlin Says No Decision Yet on Putin-Trump December Summit 



